1. Home
  2. QUBT vs NBTX Comparison

QUBT vs NBTX Comparison

Compare QUBT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

HOLD

Current Price

$7.96

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$35.60

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUBT
NBTX
Founded
2001
2003
Country
United States
France
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
QUBT
NBTX
Price
$7.96
$35.60
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$17.50
$36.00
AVG Volume (30 Days)
12.6M
80.4K
Earning Date
05-13-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
84.93
N/A
EPS
N/A
N/A
Revenue
$682,000.00
N/A
Revenue This Year
$3,210.56
$58.17
Revenue Next Year
$51.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
82.84
N/A
52 Week Low
$6.18
$4.93
52 Week High
$25.84
$57.14

Technical Indicators

Market Signals
Indicator
QUBT
NBTX
Relative Strength Index (RSI) 39.79 43.42
Support Level $7.79 $30.15
Resistance Level $13.19 $38.29
Average True Range (ATR) 0.56 2.57
MACD -0.11 -0.17
Stochastic Oscillator 20.88 9.47

Price Performance

Historical Comparison
QUBT
NBTX

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: